A detailed history of Pathstone Holdings, LLC transactions in Haleon PLC stock. As of the latest transaction made, Pathstone Holdings, LLC holds 134,319 shares of HLN stock, worth $1.31 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
134,319
Previous 134,857 0.4%
Holding current value
$1.31 Million
Previous $1.11 Million 27.67%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$8.32 - $10.7 $4,476 - $5,756
-538 Reduced 0.4%
134,319 $1.42 Million
Q2 2024

Aug 14, 2024

BUY
$8.01 - $8.64 $123,562 - $133,280
15,426 Added 12.92%
134,857 $1.11 Million
Q1 2024

May 13, 2024

SELL
$8.02 - $8.67 $123,107 - $133,084
-15,350 Reduced 11.39%
119,431 $1.01 Million
Q4 2023

Feb 14, 2024

BUY
$7.78 - $8.62 $1.05 Million - $1.16 Million
134,781 New
134,781 $1.11 Million

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $45B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Pathstone Holdings, LLC Portfolio

Follow Pathstone Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Holdings, LLC with notifications on news.